FindTrial
Sign In

Efficacy and safety of oral propranolol in the treatment of lip infantile hemangiomas: a retrospective study

Efficacy and safety of oral propranolol in the treatment of lip infantile hemangiomas: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016211
Enrollment
Unknown
Registered
2018-05-19
Start date
2015-04-01
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lip infantile hemangiomas

Interventions

localized lip infantile hemangiomas:oral propranolol
segmental lip infantile hemangiomas:oral propranolol

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) a proliferating IH located at lip that was diagnosed according to the criteria of the International Society for the Study of Vascular Anomalies (PHACES syndrome were excluded); (2) no other type of previous treatment; (3) patients who finished the therapeutic process and subsequent follow-ups with complete photo-documentation

Exclusion criteria

Exclusion criteria: Patients who are not in accord with inclusion criteria

Design outcomes

Primary

MeasureTime frame
VAS;—

Countries

China

Contacts

Public ContactWei Li

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine

liweiboshi@163.com+86 13916396121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026